Abd El-Razek Mohamed H, El-Desoky Ahmed H, Elgahamy Abdelhalim A, Bata Shaymaa M, Mohamed Tarik A, Hegazy Mohamed-Elamir F
Chemistry of Natural Compounds Department, Institute of Pharmaceutical and Drug Industries Research, National Research Centre (NRC), Giza, Egypt.
Department of Pharmacognosy, Institute of Pharmaceutical and Drug Industries Research, National Research Centre (NRC), Giza, Egypt.
Nat Prod Res. 2025 Jul;39(13):3776-3786. doi: 10.1080/14786419.2024.2315503. Epub 2024 Feb 14.
Phytochemical characterisation of the polar fraction of extract led to the isolation of glycerylerigeroside (), a unique γ-pyrone derivative. Structure of was decided by intensive study of NMR and mass spectra as 3--[4'-((1,3-dihydroxypropan-2-yl)oxy)-β-D-glucopyranoside)]-4H-pyran-4-one, with uncommon glyceroxy side chain attached to 4' position of pyromeconic acid -D-glucopyranoside. Antimicrobial potential of was tested against , , and . Compound strongly inhibited growth of (MIC = 17.24 µM/disc), compared to fluconazole (MIC = 16.33 µM/disc). Meanwhile, it moderately inhibited the growth of (MIC = 71.84 µM/disc) and (MIC = 71.84 µM/disc), as compared with thiophenicol (MIC = 14.05 µM/disc) and (MIC = 14.05 µM/disc), respectively. The binding mode of with the active site of sterol 14α-demethylase (CYP51) from (PDB ID: 5TZ1), in combination with fluconazole, was predicted by molecular docking study and supported the antifungal activity.
提取物极性部分的植物化学特征研究导致了甘油瑞香糖苷()的分离,这是一种独特的γ-吡喃酮衍生物。通过对核磁共振谱和质谱的深入研究确定了其结构为3--[4'-((1,3-二羟基丙烷-2-基)氧基)-β-D-吡喃葡萄糖苷)]-4H-吡喃-4-酮,其在焦袂康酸-D-吡喃葡萄糖苷的4'位连接有不常见的甘油氧基侧链。测试了该化合物对、和的抗菌潜力。与氟康唑(MIC = 16.33 µM/圆盘)相比,该化合物强烈抑制(MIC = 17.24 µM/圆盘)的生长。同时,与甲砜霉素(MIC = 14.05 µM/圆盘)和(MIC = 14.05 µM/圆盘)相比,它分别适度抑制(MIC = 71.84 µM/圆盘)和(MIC = 71.84 µM/圆盘)的生长。通过分子对接研究预测了该化合物与来自(PDB ID:5TZ1)的甾醇14α-去甲基化酶(CYP51)活性位点结合并与氟康唑结合的模式,这支持了其抗真菌活性。